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Galacto-Oligosaccharides: Production, Properties,
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Abstract: Galacto-oligosaccharides (GOS) have now been definitely established as prebiotic ingredients after in vitro and
animal and human in vivo studies. Currently, GOS are produced by glycoside hydrolases (GH) using lactose as substrate.
Converting lactose into GOS by GH results in mixtures containing GOS of different degrees of polymerization (DP),
unreacted lactose, and monomeric sugars (glucose and galactose). Recent and future developments in the production
of GOS aim at delivering purer and more efficient mixtures. To produce high-GOS-content mixtures, GH should not
only have good ability to catalyze the transgalactosylation reaction relative to hydrolysis, but also have low affinity for
the GOS formed relative to the affinity for lactose. In this article, several microbial GH, proposed for the synthesis of
GOS, are hierarchized according to the referred performance indicators. In addition, strategies for process improvement
are discussed. Besides the differences in purity of GOS mixtures, differences in the position of the glycosidic linkages
occur, because different enzymes have different regiochemical selectivity. Depending on oligosaccharide composition,
GOS products will vary in terms of prebiotic activity, as well as other physiological effects. This review focuses on GOS
production from synthesis to purification processes. Physicochemical characteristics, physiological effects, and applications
of these prebiotic ingredients are summarized. Regulatory aspects of GOS-containing food products are also highlighted
with emphasis on the current process of health claims evaluation in Europe.
Introduction
Lactose (β-D-galactopyranosyl-(1→4)-α-D-glucopyranose) is
a disaccharide present in the milk of all mammals, with only few
minor exceptions, in the range of concentrations of 2.0% to 10%
(w/v). The average lactose content of bovine milk is about 4.8%,
ranging between 4.4% and 5.2% (Ganzle and others 2008). During
cheese production, almost all the lactose in milk is transferred
into whey. Unlike in the past, whey is not considered a waste
anymore. Nowadays, economic and environmental considerations
dictate that whey should be used efficiently. Whey can be dried
to produce various whey powders or fractionated by membrane
technology to produce whey protein products and a permeate
stream rich in lactose (Fox 2009; Lifran and others 2009).
The most common method for large-scale production of lac-
tose directly from whey or from whey permeate is crystallization
of a supersaturated solution (Yang and Silva 1995; Paterson 2009).
In 2006, about 870000 metric tons crystalline lactose were pro-
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duced worldwide with an expected compound annual growth
rate (CAGR) between 3% and 5% until 2010 (Affertsholt-Allen
2007). Lactose has many uses in foods (infant formulas, choco-
late and confectionery products, baked items, and other processed
foods including meat products) and pharmaceuticals (as excipient
of tablets and, in finely granulated form, as a carrier of medicines
in dry powder inhalation preparations) (Schaafsma 2008).
In humans, lactose maldigestion increases with age, reaching
reported adult levels of approximately 70% of the world’s adult
population (Paige 2005). These individuals tend to avoid milk
consumption because of the risks of serious abdominal discom-
fort. The observation of this physiological event was the main
driving force for the development of commercial enzymes with
β-galactosidase activity that permitted the production of low lac-
tose products (Gekas and Lopez-Leiva 1985; Pivarnik and others
1995; Nakayama and Amachi 1999; Rehman 2009). Since lac-
tose has low solubility and low sweetness, its hydrolysis can also
be performed to decrease unwanted lactose crystallization events
in lactose-rich products during food preservation, and to increase
the range of lactose applications when sweetness is desired (Gekas
and Lopez-Leiva 1985; Pivarnik and others 1995; Nakayama and
Amachi 1999; Rehman 2009).
β-Galactosidase is a hydrolase that attacks the o-glucosyl group
of lactose. The general mechanism of enzymatic lactose hydrolysis
has a transgalactosylic nature, involving a multitude of sequen-
tial reactions with disaccharides (other than lactose) and higher
saccharides, collectively named galacto-oligosaccharides (GOS),
as intermediate products (Wallenfels and Malhotra 1960). In
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Figure 1–General model of lactose hydrolysis and
GOS synthesis. a, b, and c: 2, 3, 4, 6, (a = b),
indicate the glycosidic linkage position. X,
galactosyl donor; Y, galactosyl acceptor. In
intramolecular transgalactosylation galactosyl
donor X is also galactosyl acceptor, only linkage
position changes. Generally, lactose is the initial
substrate (a = 4 and X = Glucose). During the
progress of the reaction, generated products are
potential substrates for the enzyme. Y can have
one of the following structures: Glucose, Gal,
Gal-Gal, or [Gal]n-Glc (with 1 ≤ n ≤ 6).
processes for which lactose hydrolysis is required, such as for low
lactose or lactose-free products, GOS appear as undesirable by-
products as they can also potentially produce secondary effects.
However, the ability of those oligosaccharides, when added to
infant milk formulas, to replicate the bifidogenic effect of hu-
man milk, not only in bacterial numbers, but also with respect to
the metabolic activity of the colonic microbiota (Knol and others
2005b), has significantly increased interest in their production and
application in various food and pharmaceutical processes.
GOS were recently defined as “a mixture of those substances
produced from lactose, comprising between 2 and 8 saccharide
units, with one of these units being a terminal glucose and the re-
maining saccharide units being galactose and disaccharides com-
prising 2 units of galactose” (Tzortzis and Vulevic 2009). The
global market size of GOS was recently estimated to be about
20.000 tons with a CAGRof 10% to 20% (Affertsholt-Allen 2007).
This review on GOS focuses on production processes from
synthesis to purification. Physicochemical characteristics, physio-
logical effects, and applications of these prebiotic ingredients are
summarized.
Synthesis Strategies for Production of GOS
It is well known that oligosaccharides can be formed from
monosaccharides by the action of mineral acids (chemical synthe-
sis). This process, known as “reversion,” explains the production of
oligosaccharides during acidic hydrolysis of lactose, first observed
in the 1950s (Aronson 1952). The conditions suitable for oligosac-
charide production during acidic hydrolysis of lactose and the re-
sulting oligosaccharide structures formed have been well studied
(Huh and others 1990, 1991). It was reported that there is for-
mation of a complex mixture of disaccharides and trisaccharides,
with a variety of linkages with α- and β-anomeric configurations,
and anhydro-sugars, as a result of this chemical process (Huh and
others 1991). Probably due to the lack of product specificity and
extreme conditions applied during acidic hydrolysis of lactose, this
GOS production process is not used on a large scale.
The preferred mode for GOS synthesis is by enzymatic catal-
ysis from lactose using glycosyltransferases (EC 2.4) or glycoside
hydrolases (EC 3.2.1) (De Roode and others 2003). Glycosyltrans-
ferases and glycoside hydrolases are enzymes that are responsible
for the transfer of glycosyl moieties from a donor sugar to an accep-
tor (Ly and Withers 1999). Glycosyltransferases use sugar donors
containing a nucleoside phosphate or a lipid phosphate remaining
group (Coutinho and others 2003; Lairson and others 2008). Al-
though highly regio-selective, stereo-selective, and efficient, these
enzymes are not used for industrial GOS production due to their
unavailability, prohibitive prices of commercial enzyme prepara-
tions, and the need of specific sugar nucleotides as substrates (De
Roode and others 2003).
Currently, GOS are industrially produced using the catalytic
activity of glycoside hydrolases. These enzymes are more read-
ily available than glycosyltransferases but are generally less stereo-
selective (Tzortzis and Vulevic 2009). Enzymatic hydrolysis of the
glycosidic bond is performed by 2 catalytic residues of the en-
zyme acting as a general acid and a nucleophile/base, respectively.
Depending on the spatial position of these catalytic residues, hy-
drolysis can occur with 1 of 2 possible stereochemical outcomes:
inversion of anomeric configuration, if the average distance be-
tween the 2 catalytic residues is approximately 10 A˚; or retention
of anomeric configuration, if the average distance between the
2 catalytic residues is about 5.5 A˚. This subject has been exten-
sively reviewed by other researchers (Koshland 1953; Sinnott 1990;
Davies and Henrissat 1995; Zechel and Withers 2001).
Some retaining glycoside hydrolases are able to catalyze GOS
synthesis. Mechanistically, these enzymes are thought to oper-
ate by a 2-step reaction mechanism. The 1st irreversible step
involves formation of a configurationally inverted galactosyl-
enzyme intermediate, followed by the exit of the “leaving group.”
The covalent intermediate is subsequently hydrolyzed, again with
inversion, completing the reaction with retention of configuration
via a general acid-base catalytic mechanism (Koshland 1953; Sin-
nott 1990; Davies and Henrissat 1995; Zechel and Withers 2001).
In a well-known variant of the 2nd step, the galactosylated enzyme
may be intercepted by nucleophiles other than water, potentially
any sugar in solution, to form transgalactosylation products (GOS)
(Figure 1) (Wallenfels 1951; Pazur 1953).
Therefore, converting lactose into GOS by β-galactosidases is
a kinetically controlled reaction, by means of the competition
between hydrolysis and transgalactosylation. Specifically, during
this conversion, the thermodynamically favored hydrolysis of lac-
tose, which generates D-galactose and D-glucose, competes with
the transferase activity that generates a complex mixture of vari-
ous galactose-based di- and oligosaccharides of different structures
(Tzortzis and Vulevic 2009). Hence, knowledge of the reaction
time course (or lactose conversion) is required to determine the
point of maximum yield of the desired product.
Transgalactosylation involves both intermolecular and in-
tramolecular reactions. Intramolecular or direct galactosyl transfer
to D-glucose yields regio-isomers of lactose. Intermolecular or
indirect transgalactosylation is the route by which disaccharides,
trisaccharides, and tetrasaccharides, and eventually longer GOS,
are produced from lactose (Huber and others 1976) (Figure 1).
Alternatively to transgalactosylation from disaccharide de-
scribed previously, GOS can be obtained by reverse hydrolysis
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Table 1–Archaeal sources of glycoside hydrolases used for the production of GOS.
ARCHAEA GH T/◦C pH L0 Y Process Ref.
>Crenarchaeota
Sulfolobus solfataricus β -Galactosidase (LacS), cloned GH1 70 to 80 5.5 to 6.5 7 to 80 53 a
β -Galactosidase (LacS), cloned GH1 75 6.5 50 34 TPS b
β -Galactosidase (LacS), cloned GH1 70 5.5 4.5 to 17 23 CMAR c
>Euryarchaeota
Pyrococcus furiosus β -Glucosidase (CelB), cloned GH1 70 to 95 5.0 to 5.5 7 to 90 40 d
β -Glucosidase (CelB), mutated GH1 90 to 95 5.0 to 6.0 10 to 90 45 e
β -Glucosidase (CelB), cloned GH1 70 5.5 4.5 to 17 25 CMAR f
β -Mannosidase (BmnA), cloned GH1 90 to 95 5.0 to 5.5 10 to 70 44 g
GH, glicoside hydrolase family, if available (CAZy 2009). L0, initial lactose concentration (%, w/v). Y, maximum GOS yield reported (%) = GOS concentration/L0 × 100 (±1%). TPS, 2-phase systems; CMAR,
membrane-assisted reactor (continuous). a, Petzelbauer and others (2000b), Hansson and Adlercreutz (2001), Splechtna and others (2001), Park and others (2008); b, Hansson and Adlercreutz (2001); c,
Petzelbauer and others (2002); d, Petzelbauer and others (2000b), Hansson and others (2001); e, Hansson and others (2001); f, Petzelbauer and others (2002); g, Hansson and others (2001).
DNA cloning and expression of recombinant glycoside hydrolases was performed in E. coli.
(equilibrium synthesis) frommonosaccharides (Figure 1) (Drueck-
hammer and others 1991; Monsan and Paul 1995; Pivarnik and
others 1995; Crout and Vic 1998). Equilibrium yields are much
lower, as mainly disaccharides (around 10% to 25%, w/w) and
few percentages of trisaccharides (or higher) are formed. How-
ever, from this reaction no hydrolytic side-products are obtained,
and when combined with an effective separation process, a hypo-
thetical 100% yield is possible (Bruins and others 2003).
GOS Production
The catalysts: glycoside hydrolases
The rapid increase since the late 1980s in the number of available
amino acid sequences of glycoside hydrolases (GHs) and the avail-
ability of new sequence comparison methods permit the classifi-
cation of these enzymes based on amino acid sequence similarities
(Henrissat 1991; Henrissat and Bairoch 1996; Cantarel and others
2009). Currently, these enzymes constitute 115 protein families
(CAZy 2009). Enzymes with β-galactosidase activity (classified as
EC 3.2.1.23/108, according to substrate specificity) are grouped
within the GH1, GH2, GH35, and GH42 families. Lactose is
the natural substrate only to some enzymes belonging to GH1
and GH2, while families GH35 and GH42 include enzymes that
act on different galactose-containing glycosides (Adam and others
2004; EFSA 2010b). Some β-glucosidases from the GH1 family,
which are involved in the hydrolysis of terminal, nonreducing β-
D-glucosyl residues (EC 3.2.1.21), and β-mannosidases from the
GH1 and GH2 families, which are involved in the hydrolysis of
terminal, nonreducing β-D-mannosyl residues (EC 3.2.1.25), also
attack the o-glucosyl group of lactose, what make them suitable
for GOS synthesis (see Table 1 to 3).
Glycoside hydrolases with β-galactosidase activity occur in a
variety of microorganisms from the superkingdoms Archaea, Bac-
teria, and Eukaryota. Some of these enzymes have been expressed
in host organisms, and/or purified by a combination of several
conventional techniques, such as salting-out fractionation, ion ex-
change, gel filtration, hydroxyapatite, and hydrophobic interac-
tion chromatographies (Nakayama and Amachi 1999). A variety
of commercial glycoside hydrolases with β-galactosidase activity
are commercially available for use in food processing (Richmond
and others 1981; Gekas and Lopez-Leiva 1985; Pivarnik and oth-
ers 1995; Panesar and others 2006), and some of them are already
used in the industrial production of GOS as discussed in a section
previously. Nevertheless, there is continuous interest in finding
microorganisms with adequate properties for industrial uses and
able to produce specific GOS mixtures with better yields.
The product spectrum obtained during lactose conversion, the
linkage between the galactose units, and the efficiency of trans-
galactosylation all depend on the enzyme source and the physic-
ochemical conditions in the catalytic environment. Interactions
between the galactosyl acceptor and the active site of the enzyme
are thought to play a major role in the formation of intermolecu-
lar galactosyl transfer products (Petzelbauer and others 2000a). In
other words, the enzyme ability to accommodate the galactosyl
acceptor in the neighborhood of the active site during the cat-
alytic moment, and the spatial orientation of the galactosyl accep-
tor, are probable key factors in the transgalactosylation efficiency
and in the position of new glycosidic linkages (see Figure 2 and
Table 4).
Glucose/galactose ratio at the maximum GOS yield was de-
termined to quantify the ability of different enzymes to catalyze
the transgalactosylation reaction (to lactose or galactose acceptors)
relative to complete hydrolysis (Figure 2). This ratio should be
higher than 1 because some of the galactose produced by lac-
tose cleavage was transferred to oligosaccharides, whereas all the
glucose was released. It should be noted that this ratio does not
take into account the transfer of the galactosyl moiety to free glu-
cose via intermolecular reaction or via intramolecular reaction (see
Figure 1 for details).
Process improvement
Generally, the yield of GOS synthesis from lactose using gly-
coside hydrolases can be increased by: using highly concentrated
starting lactose solution; decreasing water thermodynamic activ-
ity (for example, using a micro-aqueous environment); removing
the final product and/or inhibitors from the reaction medium;
and modifying the enzyme (Monsan and Paul 1995; Czermak and
others 2004).
Using highly concentrated starting lactose solution. Data
gleaned from the literature show that maximum GOS yield is
largely influenced by initial lactose concentration (L0) mainly, un-
til the concentration range is 30% to 40% (w/v). For L0 > 30%
the influence of L0 in GOS yield markedly decreases (Figure 3).
Data from A. oryzae, A. aculeatus, and B. longum (not represented)
are more scattered but show a similar behavior for L0 > 40%.
Since lactose solubility is relatively low at room temperature
but manifestly increases with increasing temperature (Roos 2009),
high temperatures are generally desired. Some studies have been
focused on sourcing thermostable glycoside hydrolases. Glycoside
hydrolases from S. solfataricus (Petzelbauer and others 2000b; Hans-
son and Adlercreutz 2001; Splechtna and others 2001; Park and
others 2008), P. furiosus (Petzelbauer and others 2000b; Hansson
and others 2001), Thermus sp. (Akiyama and others 2001), T. cal-
dophilus (Choi and others 2003), C. saccharolyticus (Stevenson and
others 1996), T. maritima (Kim and others 2004; Ji and others 2005)
are examples of enzymes from hyperthermophil microorganisms
used at temperatures around 80 ◦C and higher.
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Table 2–Bacterial sources of glycoside hydrolases used for the production of GOS.
BACTERIA GH T/◦C pH L0 Y I Process Ref.
>Actinobacteria
Saccharopolyspora rectivirgula β -Galactosidase, purified GH2 70 7.0 60 44 a
Bifidobacterium adolescentis Crude enzyme fraction 55 7.5 30 43 b
Bifidobacterium angulatum Crude enzyme fraction 55 7.5 5 to 30 44 c
Bifidobacterium bifidum β -Galactosidase (BIF3), mutated GH2 37 6.0 10 to 40 44 d
Crude enzyme fraction 55 7.5 30 38 e
Cells, resting cells 39 6.8 50 20 f
Cells, toluene-treated, resting cells 40 6.2 to 6.8 45 to 50 44 g
Cells, toluene-treated, resting cells 40 5.0 to 5.5 Whey, 45 to 50 38 h
Bifidobacterium longum subsp. β -Galactosidase (β -GalI), cloned# GH2 30 6.5 36 49 I
infantis∗
β -Galactosidase (β -GalI), cloned GH2 30 to 60 7.5 20 to 30 68 j
β -Galactosidase, (β -GalIII), cloned GH42 37 7.5 20 10 k
Crude enzyme fraction 55 7.5 30 48 l
Cells, in culture 60 7.5 Milk, 35 43 m
Bifidobacterium longum Crude enzyme fraction 45 6.8 5 to 50 35 n
Bifidobacterium pseudolongum Crude enzyme fraction 55 7.5 30 27 o
>Deinococcus-Thermus
Thermus sp. β -Glucosidase, cloned GH1 70 7.0 7.5 to 30 40 p
Thermus caldophilus β -Glucosidase (BglA) cloned GH1 70 to 80 6.0 30 to 50 77 q
>Thermotogae
Thermotoga maritima β -Galactosidase (LacZ), cloned GH2 80 6.0 20 to 50 19 r
>Firmicutes
Bacillus circulans β -Galactosidase (I), purified 40 6.0 4.6 6.0 s
40 6.0 4.3 40 SG t
β -Galactosidase (II), purified 40 6.0 4.6 41 u
40 6.0 4.6 to 20 48 SG PBR v
40 6.0 4.6 35 PR PBR w
Crude enzyme fraction 40 to 55 6.0 6.5 to 36 43 x
Bacillus sp. Crude enzyme fraction 50 to 55 5.0 33 to 36 43 y
55 5.0 36 41 Chitosan z
Geobacillus stearothermophilus β -Galactosidase (BgaB) GH42 37 6.5 17 2.4 aa
β -Galactosidase (BgaB), mutated GH42 37 6.5 17 30 ab
Caldicellulosiruptor β -Glucosidase (Bgla), cloned GH1 65 to 80 6.3 10 to 72 63 ac
saccharolyticus∗∗
Lactobacillus acidophilus β -Galactosidase (LacL+LacM), cloned GH2 30 6.5 21 39 ad
Lactobacillus reuteri β -Galactosidase (LacL+LacM), cloned GH2 23 6.0 21 26 ae
β -Galactosidase (LacL+LacM), purified GH2 30 to 37 6.0 to 6.5 4.6 to 21 38 af
GH2 37 6.0 21 29 CMAR ag
Streptococcus thermophilus β -Galactosidase (LacZ), purified GH2 37 – Milk, 5.3 25 ah
>Proteobacteria
Enterobacter agglomerans∗∗∗ β -Galactosidase (LacZ), cloned GH2 50 7.5 5 to 13 38 ai
Enterobacter cloacae β -Galactosidase, (Bga/LacZ), cloned GH2 50 6.5 28 49 aj
Cells, resting 50 6.5 28 55 ak
Escherichia coli β -Galactosidase (LacZ), purified GH2 30 to 37 6.5 to 7.2 2.2 to 24 56 al
37 7.5 2.2 44 RM am
GH, glicoside hydrolase family, if available (CAZy 2009). L0, initial lactose concentration (%, w/v). Y, maximum GOS yield reported (%) = GOS concentration/L0 × 100 (± 1%). I, immobilization support. SG,
silica gel; PR, phenolformaldehyde resin; PBR, packed bed reactor (continuous); CMAR, membrane-assisted reactor (continuous); RM, dioctyl sodium sulfosuccinate/isooctane reverse micelles. a, Nakao and
others (1994); b, Rabiu and others (2001); c, Rabiu and others (2001); d, Jorgensen and others (2001); e, Rabiu and others (2001); f, Tzortzis and others (2005b); g, Goulas and others (2007a); h, Goulas and
others (2007a); i, Jung and Lee (2008); j, Hung and others (2001), Hung and Lee (2002); k, Hung and others (2001); l, Rabiu and others (2001); m, Roy and others (2002); n, Hsu and others (2007); o, Rabiu and
others (2001); p, Akiyama and others (2001); q, Choi and others (2003); r, Kim and others (2004), Ji and others (2005); s, Mozaffar and others (1984); t, Mozaffar and others (1987); u, Mozaffar and others
(1984); v, Mozaffar and others (1986); w, Mozaffar and others (1986); x, Boon and others (1999, 2000a), Cheng and others (2006c); y, Cheng and others (2006a, 2006c); z, Cheng and others (2006c); aa, Placier
and others (2009); ab, Placier and others (2009); ac, Stevenson and others (1996); ad, Nguyen and others (2007); ae, Maischberger and others (2008); af, Splechtna and others (2006, 2007); ag, Splechtna and
others (2007); ah, Greenberg and Mahoney (1983); ai, Lu and others (2007); aj, Lu and others (2009); ak, Lu and others (2009); al, Huber and others (1976), Chen and others (2003); am, Chen and others
(2003). ∗Bifidobacterium longum subsp. infantis synonym: Bifidobacterium infantis; ∗∗ Caldicellulosiruptor saccharolyticus synonym: Caldocellum saccharolyticum; ∗∗∗ Enterobacter agglomerans synonym:
Pantoea agglomerans; DNA cloning and expression of recombinant glycoside hydrolases was performed in E. coli except # cloned into Pichia pastoris.
High temperature also seems to favor transgalactosylation rel-
ative to hydrolysis. An increase in reaction temperature signifi-
cantly increases GOS yield when glycoside hydrolases from A.
aculeatus (Cardelle-Cobas and others 2008), S. solfataricus, or P. fu-
riosus (Hansson and Adlercreutz 2001) were used. However, other
researchers found only a slight or no correlation between tem-
perature and GOS yield using P. furiosus (Boon and others 1998;
Petzelbauer and others 2002), S. solfataricus (Petzelbauer and others
2002), B. circulans, A. oryzae, K . lactis, and K. marxianus (Boon and
others 2000a).
The use of microwave irradiation as a nonconventional energy
source during GOS synthesis was also successfuly attempted using
an immobilized crude enzyme preparation from K. lactis at 40 ◦C
(Maugard and others 2003). Maximum GOS yield increased from
24% to 28% when initial lactose concentration was 16% (w/v).
Decreasingwater thermodynamicactivity. An example of using
a micro-aqueous environment to decrease water thermodynamic
activity during GOS synthesis is the use of reverse micelles. A
similar transgalactosylation capability was obtained at low lactose
concentration when reverse micelles were used, as compared to
that reported at high lactose concentration in an aqueous system
(Chen and others 2001, 2003).
Aqueous 2-phase systems appear to increase the transgalactosy-
lation yield in comparison with usual aqueous solution probably
due to the partitioning of the desired product, inhibitors, and the
enzyme between the 2 phases of the system. The glucose/galactose
ratio at maximum GOS yield using a crude enzyme fraction from
A. aculeatus increased from 2.2 to 12.7 (Figure 2) when an aqueous
2-phase system is used, reflecting an advantageous environment for
galactosyl transfer reactions (Del-Val and Otero 2003).
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Table 3–Fungal sources of glycoside hydrolases used for the production of GOS.
EUKARYOTA GH T/◦C pH L0 Y I Process Ref.
>Ascomycota
Aspergillus aculeatus Crude enzyme fraction 45 to 60 4.5 to 6.5 10 to 57 25 a
45 to 50 6.5 21 to 24 24 ATPS b
50 6.5 30 15 HAB c
Aspergillus niger Crude enzyme fraction 40 7.0 2 to 30 16 d
Aspergillus oryzae Crude enzyme fraction 40 to 80 4.5 to 7.0 1 to 72 35 e
45 7.0 10 to 50 51 RM f
40 4.5 27 22 MA g
50 to 55 4.5 to 4.7 17 to 30 31 CMAR h
35 to 50 4.5 to 5.0 Whey, 4 to 23 18 i
40 4.0 to 4.5 10 to 30 26 Chitosan j
40 4.5 5 to 50 27 Cotton k
40 4.5 27 20 Cotton PB l
40 4.5 5 to 50 26 Cotton PBR m
40 4.5 5 to 50 26 mPOS-PVA n
40 4.5 5 to 50 26 mPOS–PANI o
40 4.5 Whey, 6 to 20 14 PVC-film PBR p
Penicillium expansum Crude enzyme fraction GH35 50 5.4 5.0 to 48 29 Alginate q
CSDS, Saccharomyces cerevisiae, GH35 25 — 5 to 25 44 r
in culture
Penicillium funiculosum Crude enzyme fraction 40 5.0 5.0 20 s
Penicillium simplicissimum β -Galactosidase, purified 50 6.5 30 to 60 30 t
Talaromyces thermophilus β -Galactosidase, purified 40 6.5 20 50 u
40 6.5 5.0 to 20 41 HAB v
40 6.5 20 25 HAB PBR w
Trichoderma harzianum Cells, in culture 30 7.0 15 32 x
Kluyveromyces lactis∗ Crude enzyme fraction 24 to 50 5.0 to 7.5 5.0 to 40 38 y
40 6.9 to 7.5 17 to 31 43 CMAR z
40 6.5 8.0 to 32 28 AER aa
40 6.5 16 28 AER MW ab
37 6.6 3.0 to 13 7.4 Cotton PBR ac
35 to 45 7.0 Whey, 14 to 23 22 ad
45 7.0 Whey, 20 31 CMAR ae
Kluyveromyces marxianus∗∗ Crude enzyme fraction 35 to 40 6.2 to 7.0 5.0 to 50 45 af
45 7.0 Whey, 14 to 23 24 ag
>Basidiomycota
Sirobasidium magnum β -Galactosidase, purified 60 5.0 20 36 ah
Cells, in culture 30 6.0 36 62 ai
Cells, toluene-treated, resting cells 50 6.0 36 38 aj
Sterigmatomyces elviae β -Galactosidase, purified 60 5.0 20 38 ak
Cells, in culture 30 6.0 36 64 al
Cells, toluene-treated, resting cells 30 6.0 36 38 am
Rhodotorula minuta β -Glucosidase, purified 60 5.0 20 39 an
Cells, in culture 30 6.0 36 64 ao
Cells, toluene-treated, resting cells 60 6.0 20 39 ap
Sporobolomyces singularis∗∗∗ β -Glucosidase (Bgla), purified GH1 37 to 50 3.7 to 6.0 18 to 30 54 aq
β -Glucosidase, purified GH1 45 4.8 10 55 Chitosan PBR ar
GH1 37 6.0 Whey, 20 34 as
Cells, resting cells 55 5.0 60 41 at
Cells, resting cells 55 5.0 60 40 Alginate au
CSDS, cell-surface display system (β -Galactosidase gene from P. expansum expressed on the cell surface of S. cerevisiae); GH, glicoside hydrolase family, if available (CAZy 2009). L0, initial lactose concentration
(%, w/v). Y, maximum GOS yield reported (%) = GOS concentration/L0 × 100 (± 1%). I, immobilization support. HAB, hydrophilic acrylic beads (Eupergit C®); mPOS-PVA, magnetic polysiloxane-polyvinyl
alcohol; mPOS–PANI, magnetic polysiloxane–polyaniline; PVC-film, polyvinyl chloride film; AER, anion exchange resin; ATPS, aqueous 2-phase systems; RM, dioctyl sodium sulfosuccinate/isooctane reverse
micelles; MA, recycled membrane-assisted system; CMAR, membrane-assisted reactor (continuous); PB, packed bed assisted system; PBR, packed bed reactor (continuous); MW, microwave power 12 watt.
a, Del-Val and others (2001), Del-Val and Otero (2003), Aslan and Tanriseven (2007), Cardelle-Cobas and others (2008); b, Del-Val and Otero (2003); c, Aslan and Tanriseven (2007); d, Toba and Adachi
(1978), Prenosil and others (1987); e, Prenosil and others (1987), Iwasaki and others (1996), Stevenson and others (1996), Boon and others (2000b), Chen and others (2001), Cheng and others (2006a), Gaur
and others (2006), Matella and others (2006), Neri and others (2009a); f, Chen and others (2001); g, Matella and others (2006); h, Czermak and others (2004), Ebrahimi and others (2006b); i, Prenosil and
others (1987), Rustom and others (1998); j, Sheu and others (1998), Gaur and others (2006); k, Albayrak and Yang (2002a, 2002b, 2002c), Matella and others (2006); l, Matella and others (2006); m, Albayrak
and Yang (2002b); n, Neri and others (2009a); o, Neri and others (2009b); p, Leiva and Guzman (1995); q, Li and others (2008); r, Li and others (2009); s, Shin and Yang (1996); t, Cruz and others (1999); u,
Nakkharat and Haltrich (2007); v, Nakkharat and Haltrich (2006, 2007); w, Nakkharat and Haltrich (2007); x, Prakash and others (1987); y, Burvall and others (1979), Boon and others (2000a), Kim and others
(2001), Chockchaisawasdee and others (2005), Cheng and others (2006a), Martinez-Villaluenga and others (2008); z, Czermak and others (2004), Ebrahimi and others (2006a), Engel and others (2008); aa,
Maugard and others (2003); ab, Maugard and others (2003); ac, Zhou and others (2003); ad, Rustom and others (1998); Foda and Lopez-Leiva (2000); ae, Foda and Lopez-Leiva (2000); af, Roberts and Pettinati
(1957), Toba and Adachi (1978), Jeon and Mantha (1985), Boon and others (2000a); ag, Rustom and others (1998); ah, Onishi and Tanaka (1997); ai, Onishi and others (1996); aj, Onishi and others (1996); ak,
Onishi and Tanaka (1995); al, Onishi and others (1995); am, Onishi and others (1995); an, Onishi and Tanaka (1996); ao, Onishi and Tanaka (1996); ap, Onishi and Tanaka (1996); aq, Shin and others (1998),
Cho and others (2003); ar, Shin and others (1998); as, Cho and others (2003); at, Sakai and others (2008); au, Sakai and others (2008). ∗Kluyveromyces lactis synonym: Kluyveromyces marxianus var. lactis; ∗∗
Kluyveromyces marxianus synonyms: Kluyveromyces fragilis, Saccharomyces fragilis; ∗∗∗ Sporobolomyces singularis synonym: Bullera singularis.
Modifying the enzyme. Optimization of the enzyme structure
can contribute to increasing the maximum GOS yield from lac-
tose. A protein engineering approach was applied to β-glucosidase
from P. furiosus. An increase in GOS yield was observed by chang-
ing phenylalanine 426 residue to tyrosine (Table 1). By changing
an additional residue, methionine 424 to a lysine, better transgalac-
tosylation properties at low lactose concentrations were obtained
(Hansson and others 2001). More recently, a similar approach was
applied to the β-galactosidase from G. stearothermophilus. When
the arginine 109 residue on the active site was changed to lysine,
valine, or tryptophan, trisaccharide yield increased from 2% to
12%, 21% and 23%, respectively (Placier and others 2009).
Deletion mutagenesis of the C-terminal part turned the
β-galactosidase from B. bifidum into a high-efficient transgalac-
tosylating enzyme (Table 2) characteristically noninfluenced by
lactose concentration (Jorgensen and others 2001). At maximum
GOS yield the glucose/galactose ratio in the reaction media is
much higher using this truncated β-galactosidase from B. bifidum
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than that obtained with other β-galactosidases from the genus
Bifidobacterium (Figure 2).
Transgalactosylation activity of the β-galactosidase-1 from B.
circulans was increased by modification of the enzyme with glu-
taraldehyde (Table 2), probably due to conformational changes
near the active site of the enzyme (Mozaffar and others 1987).
This is an example of a chemical-induced structural change, par-
ticularly interesting since glutaraldehyde is commonly used as a
crosslinking agent for covalent enzyme immobilization.
Removing the final product and/or inhibitors from the reaction
medium. Membrane-assisted, continuously stirred tank reactors
have been used for GOS synthesis. An advantage of this type of
scheme is that the product is continuously removed (along with
water, some substrate, and simple sugar by-products) from the
stirred tank using cross-flow membrane ultrafiltration, while the
enzyme is retained. This configuration also allows variation of
the residence time aiming at the optimization of the yield and
composition of the oligosaccharides fraction (Czermak and others
2004). The yield of GOS produced by glucosidase from S. sol-
fataricus at 30% and 70% lactose conversion was 3- and 1.3-fold
higher, respectively, in the continuous reactor as compared to the
results obtained in the batch reactor (Petzelbauer and others 2002).
When compared with the batch process, higher yields of GOS us-
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Figure 2–Glucose/galactose ratios at maximum GOS yield of glycoside
hydrolases from different microbial sources. ARCHAEA: 1, S. solfataricus
(Petzelbauer and others 2000b); 2, P. furiosus (Petzelbauer and others
2000b); BACTERIA: 3, S. rectivirgula (Nakao and others 1994); 4, B.
bifidum (BIF3, mutated) (Jorgensen and others 2001); 5, B. infantis
(β-GalI) (Hung and Lee 2002); 6, B. infantis (β-GalIII) (Hung and Lee
2002); 7, B. longum (Hsu and others 2007); 8, Thermus sp. (Akiyama and
others 2001); 9, B. circulans (Boon and others 1999); 10, Bacillus sp.
(Cheng and others 2006c); 11, G. stearothermophilus (wild-type) (Placier
and others 2009); 11∗, G. stearothermophilus (mutated) (Placier and
others 2009); 12, L. acidophilus (Nguyen and others 2007); 13, L. reuteri
(Splechtna and others 2006); 14, S. thermophilus (Greenberg and
Mahoney 1983); 15, C. saccharolyticus (Stevenson and others 1996); 16,
T. maritima (Ji and others 2005); FUNGI: 17, A. aculeatus (Cardelle-Cobas
and others 2008); 17∗∗, A. aculeatus (aqueous 2-phase systems) (Del-Val
and Otero 2003); 18, A. oryzae (Matella and others 2006); 19, T.
thermophilus (Nakkharat and Haltrich 2007); 20, P. expansum (Li and
others 2008); 21, P. funiculosum (Shin and Yang 1996); 22, P.
simplicissimum (Cruz and others 1999); 23, K. marxianus (Roberts and
Pettinati 1957); 24, K. lactis (Chockchaisawasdee and others 2005); 25,
S. magnum (Onishi and Tanaka 1997); 26, S. singularis (Ishikawa and
others 2005); 27, R. minuta (Onishi and Tanaka 1996); 28, S. elviae
(Onishi and Tanaka 1995). (Data extracted from the literature.)
ing membrane-assisted continuously stirred tank reactors were also
observed during lactose conversion (in solution or in whey) with
enzymes from K. lactis (Table 3). Increases in GOS yield can be
explained by a more efficient transfer of galactosyl residues to glu-
cose and lactose, and a smaller extent of secondary degradation
of GOS in the steady state, as compared to batch reactor (Pet-
zelbauer and others 2002; Czermak and others 2004). However,
this advantage was not observed using glycoside hydrolases from P.
furiosus (Petzelbauer and others 2002), L. reuteri (Table 2), and A.
oryzae (Table 3). These differences result from the distinct kinetic
properties of the enzymes involved.
Contrary to the batch operation mode, where the composition
of the different saccharides is changing constantly over the reaction
time/lactose conversion, in the steady state of a continuous system
the composition of the mixture stays constant over time. The
composition of GOS mixtures can be finely tuned by controlling
the residence time of a continuous system (Petzelbauer and others
2002; Czermak and others 2004; Chockchaisawasdee and others
2005; Splechtna and others 2007).
GOS yield and lactose conversion
As already discussed, the efficiency of the transgalactosylation
reaction is kinetically controlled, as GOS are potential substrates
of the glycoside hydrolase enzyme. The formation of oligosac-
charides reaches a maximum time-course during a batch reaction.
After the maximum point, GOS concentration decreases until ap-
proximately zero when lactose conversion is around 100%. The
increase in the maximum amount of oligosaccharides can be due
either to the enzyme ability to catalyze the transgalactosylation
reaction relative to hydrolysis (as discussed previously) and/or to a
lower rate of breakdown of the oligosaccharide products relative to
lactose, probably because of the much higher km (affinity) values
for GOS than for lactose. The enzyme ability could explain the
differences observed in Figure 3 regarding the GOS yield (y axis),
while the lower rate of GOS breakdown may explain the different
lactose conversion rates obtained (x axis).
As reported in the literature, maximum yields of GOS between
15% and 77% are achieved when lactose conversion is between
45% and 95% depending on the enzyme source and the production
process (Figure 3). If, with a given enzyme, a maximum yield of
GOS is obtained for a high lactose conversion (examples: glycoside
hydrolases from T. caldophilus, S. thermophilus, or K. marxianus),
that is probably because it has higher km values for GOS than for
lactose.
Enzymes, cells, or resting cells
Processes for GOS production from lactose can be roughly clas-
sified into those employing enzymes extracted from microbial
cells, with variable purity; those where a specific microorganism
is cultured in a lactose-containing medium; and finally those that
use resting cells of a lactose-utilizing microorganism acting as a
so-called enzyme bag (Dombou and others 1992).
The former process requires the extraction of enzymes, which
means additional costs and time consumption. Moreover, as hy-
drolysis of lactose and GOS is, to some extent, inevitable, ac-
cumulation of glucose and galactose as by-products occurs. The
presence of these monosaccharides is generally reported as unde-
sirable since the objective is to produce tri- and larger oligosac-
charides. Galactose and glucose were reported as inhibitors of
glycoside hydrolases from K. lactis (Chockchaisawasdee and oth-
ers 2005) and from S. elviae (Onishi and others 1995), respec-
tively, regarding GOS formation. However, an unexpected positive
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Figure 3–The effect of initial lactose concentration on maximum GOS
yield. , S. solfataricus (Petzelbauer and others 2000b; Splechtna and
others 2001; Park and others 2008);, P. furiosus (Petzelbauer and
others 2000b; Hansson and others 2001); –, B. angulatum (Rabiu and
others 2001);, T. caldophilus and Thermus sp. (Akiyama and others
2001; Choi and others 2003); , T. maritime (Kim and others 2004; Ji and
others 2005);♦, A. niger (Toba and Adachi 1978; Prenosil and others
1987);, P. expansum (Li and others 2008); ◦, P. simplississum (Cruz and
others 1999);, K. lactis (Burvall and others 1979; Boon and others
2000a; Chockchaisawasdee and others 2005; Cheng and others 2006a;
Martinez-Villaluenga and others 2008); ×, K. marxianus (Roberts and
Pettinati 1957); +, S. singularis (Shin and others 1998; Cho and others
2003; Ishikawa and others 2005). Maximum GOS yield is normalized to
reduce the enzyme source effect.
effect of these monosaccharides on GOS yield was observed when
using B. bifidum resting cells (Goulas and others 2007a).
Culture-based processes can be conducted if glycoside hydro-
lases expressed by the microorganism are cell-bound or secreted
into the culture medium. One of the advantages of cultured-based
processes is that glucose and galactose can be consumed during
cell growth reducing their content in the final saccharide mixture,
thus improving GOS yield. Higher GOS yields were reported us-
ing fermentation systems with microorganisms from the species
S. elviae, S. magnum, or R. minuta growing on lactose compar-
ing to processes using resting cells or purified enzymes from the
same microorganisms (Table 3 and Figure 4) (Onishi and others
1995, 1996; Onishi and Tanaka 1996, 1997). These researchers
concluded that these improved GOS yields result from the fact
that the glucose is consumed for cell growth, since glucose has
been found to inhibit GOS synthesis. More recently, an inno-
vative strategy for GOS synthesis by anchoring β-galactosidase
from P. expansum on the cell surface of S. cerevisiae as an im-
mobilized enzyme was also successfully applied (Li and others
2009).
On the other hand, GOS must be separated from accumulated
secreted microbial products and from other ingredients essential
or useful for cell growth incorporated in the culture medium
(nitrogen sources, vitamins, trace elements, among others).
Industrial GOS producers use either cells or enzyme extracts.
For example, C. laurentii resting cells entrapped in calcium alginate
gels are used for industrial-scale production of GOS. Furthermore,
GOS are also produced by means of a sequential reaction of a
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Figure 4–Maximum reported yield of GOS as a function of reported
conversion., enzyme; , cells. Data extracted from the literature.
ARCHAEA: 1, S. solfataricus (Park and others 2008); 2, P. furiosus
(Petzelbauer and others 2000b); BACTERIA: 3, S. rectivirgula (Nakao and
others 1994); 4, B. bifidum (BIF3, mutated) (Jorgensen and others 2001);
5, B. bifidum (Tzortzis and others 2005b); 6, B. infantis (β-GalI) (Hung and
Lee 2002); 7, B. longum (Hsu and others 2007); 8 T. caldophilus (Choi and
others 2003); 9, Thermus sp. (Cheng and others 2006c); 10, B. circulans
(β-GalII) (Mozaffar and others 1984); 11, B. circulans (Boon and others
1999); 12, Bacillus sp. (Cheng and others 2006a); 13, G.
stearothermophilus (Placier and others 2009); 14, C. saccharolyticum
(Stevenson and others 1996); 15, L. acidophilus (Nguyen and others
2007); 16, L. reuteri (Splechtna and others 2006); 17, S. thermophilus
(Greenberg and Mahoney 1983); 18, E. coli (Huber and others 1976); 19,
T. maritima (Ji and others 2005); FUNGI: 20, A. aculeatus (Cardelle-Cobas
and others 2008); 21, A. niger (Toba and Adachi 1978); 22, A. oryzae
(Iwasaki and others 1996); 23, P. expansum (Li and others 2008); 24, P.
expansum (β-galactosidase gene from P. expansum expressed on the cell
surface of S. cerevisiae) (Li and others 2009); 25, P. funiculosum (Shin and
Yang 1996); 26, P. simplicissimum (Cruz and others 1999); 27, T.
thermophilus (Nakkharat and Haltrich 2007); 28, K. lactis (Cheng and
others 2006b); 29, K. marxianus (Roberts and Pettinati 1957); 30, S.
magnum (Onishi and Tanaka 1997); 31, S. magnum (Onishi and others
1996); 32, S. elviae (Onishi and Tanaka 1995); 33, S. elviae (Onishi and
others 1995); 34, R. minuta (Onishi and Tanaka 1996); 35, R. minuta
(Onishi and Yokozeki 1996); 36, S. singularis (Shin and others 1998); 37,
S. singularis (Sakai and others 2008).
lactose solution with A. oryzae β-galactosidase and S. thermophilus
β-galactosidase, respectively (Nakayama and Amachi 1999).
Nevertheless, it is important to notice that the production of
GOSmixtures using microbial cultures can occur as a consequence
of the multiple glycoside hydrolases expressed by some microor-
ganisms. Thus, this combined activity of several enzymes limits the
fermentation process modeling and control. As examples, 2 glyco-
side hydrolases from B. circulans (Mozaffar and others 1984), 3 from
A. niger (Widmer and Leuba 1979), 3 from B. bifidum DSM20215
(Moller and others 2001), and 4 from B. bifidum NCIMB41171
(Goulas and others 2007b) have been reported.
High-content GOS production
GOS mixtures produced by transgalactosylation always contain
considerable amounts of nonreacted lactose and monosaccharides.
The efficient removal of these non-GOS impurities allows the
commercialization of added-value GOS products (Crittenden and
Playne 2002).
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Table 5–Chemical composition of commercial GOS (w/w dry matter).
GOS
Glucose Galactose Lactose DP2 DP3 DP4 DP > 4 Total Enzyme source Ref.
CUP-oligo 25 to 30i – – – – 70 Cryptococcus laurentii a
Oligomate 55 18 to 39ii 10 to 22 15 to 17 18 to 24 10 to 16 2 to 5.4 50 to 60 A. oryzae and S. thermophilus b
TOS-100 0ii 0 to 1 0 55 33 to 35 12 to 14 99 to 100 A. oryzae and S. thermophilus c
Vivinal GOS 19 to 22 0.8 to 1.3 10 to 23 19 to 27 22 to 23 11 6.0 to 7.6 57 to 59 Bacillus circulans d
Bimuno 18 12 22 25 to 29 12 to 14 6.7 to 7.7 3.8 to 4.4 48 to 55 Bifidobacterium bifidum e
Purimune 0 to 1.0 0 to 0.5 7.0 to 10 16 to 21 38 to 51 25 to 29iii 90 to 92 Bacillus circulans f
Promovita GOS – – – – – – – – –
Nissin Sugar Manufacturing Co. (Tokyo, Japan): Cup-Oligo in syrup (Cup-Oligo H70, 75% solids) and powder format (Cup-Oligo P); Yakult Honsha (Tokyo, Japan): Oligomate 55 syrup (75% dry matter);
Oligomate 55P (powder); TOS-100. Yakult now also uses B. circulans to produce β 1→4 linked products. A preparation containing trans-galactosylated disaccharides has been reported and manufactured using
β -galactosidase from S. thermophilus (Ito and others 1993); Friesland Foods Domo (Zwolle, The Netherlands) is offering Vivinal GOS in a syrup (73% dry matter) and 2 powder formats, Vivinal 10 and Vivinal 15,
obtained co-spray-drying Vivinal GOS syrup and whey protein concentrate or maltodextrin, respectively; Clasado Ltd. (Milton Keynes, U.K.) offers a powder GOS product, Bimuno, as well as a syrup version; Corn
Products Intl., Inc. (Ill., U.S.A.): Purimune (powder); Fayrefield Food (Crewe, U.K.) and First Milk (Paisley, U.K.): Promovita GOS (syrup);
iglucose + galactose + lactose; ii glucose + galactose; iii DP≥ 4; (-) no data available.
a, Hartemink and others (1997), Playne and Crittenden (2009); b, Ito and others (1990), Katta and others (2000), Sar and others (2004), Splechtna and others (2006); c, Ito and others (1990), Rowland and
Tanaka (1993); d, Goulas and others (2007a), Coulier and others (2009), Sinclair and others (2009); e, Vulevic and others (2008), Silk and others (2009), Tzortzis (2009); f, GTC Nutrition (2009).
Large-scale separation of monosaccharides is usually con-
ducted by a chromatographic process with ion-exchange resins
or activated charcoal (Hernandez and others 2009; Nobre and
others 2009). Regarding ion-exchange chromatography, the
cation-exchange resins are the most used as they have the highest
affinity for monosaccharides, and therefore oligosaccharides are
the first to elute from the column. Activated charcoal has been
reported to possess a higher affinity for oligosaccharides compared
to mono- and disaccharides, which makes their operation at the
industrial level more advantageous, since regeneration can take
place off-line without large substrate losses.
Recently, a comparison of fractionation techniques to obtain
high-content GOS mixtures, at preparative scale, concluded that
size-exclusion chromatography was the most appropriate method
to obtain fractions with high purity, enabling the purification of
GOS with different degrees of polymerization (DP) (Hernandez
and others 2009). Although not in a mature stage, membrane
techniques, particularly nanofiltration, also show potential for
large-scale fractionation of oligosaccharides from complex mix-
tures (Goulas and others 2002, 2003; Feng and others 2009). Su-
percritical fluid extraction technology also has shown satisfactory
performances in the isolation of monosaccharides, disaccharides,
and higher saccharides from complex mixtures (Montanes and
others 2009).
Furthermore, other approaches based on the selective fermen-
tation characteristics for a given microorganism have been pro-
posed. During these fermentation processes, depending on the
microorganism, ethanol can be produced and, if in toxic concen-
trations, its activity can be compromised. S. cerevisiae was used to
improve the purity of a commercial mixture of GOS obtained
with β-galactosidase from B. circulans by completely removing the
monosaccharides (Hernandez and others 2009). The same ap-
proach was applied to a GOS mixture produced by B. bifidum
biomass (Goulas and others 2007a). K. marxianus was used to im-
prove the purity of a GOS mixture produced by β-galactosidase
from B. circulans from 38% to 97% by selective fermentation of
mono- and disaccharides (including lactose) (Cheng and others
2006a). A combination of S. cerevisae and K. lactis was used to im-
prove the purity of a GOS mixture produced by β-galactosidase
from P. expansum from 29% to 98% by selective fermentation of
monosaccharides and lactose (Li and others 2008).
The separation of lactose from a disaccharide fraction has proven
to be difficult by all the reported processes, and usually results in
large losses of GOS products, mainly nonlactose disaccharides.
To overcome this difficulty, a process where lactose is efficiently
separated from other sugars by anion-exchange chromatography,
after its selective oxidation into lactobionic acid using a fungal
cellobiose dehydrogenase, was proposed by Splechtna and others
(2001). However, with this process, total losses of GOS around
17% occur, since the fungal cellobiose dehydrogenases used are
not specific for lactose (Splechtna and others 2001; Maischberger
and others 2008).
Commercially available GOS
GOS have been manufactured and commercialized by Yakult
Honsha and Nissin Sugar Manufacturing from Japan, by Corn
Products Intl. from the United States, and by Borculo Domo In-
gredients and Clasado from Europe. Also, some companies have
been reported to produce GOS for incorporating in their own
products rather than for commercial purposes (Playne and Crit-
tenden 2009). Recently, new players have come into the market,
but available information on their products is scarce (Table 5).
Food-grade GOS are usually transparent syrups or white powders.
In both cases, they are mixtures containing oligosaccharides of
different DP, the nonreacted lactose and monomer sugars (glucose
and galactose) (Playne and Crittenden 2009; Tzortzis and Vulevic
2009). Purified products with more than 90% (w/w) GOS are
available from some manufacturers.
Besides the differences in the purity amongst the commercially
offered products, there are differences also in the linkages of the
oligosaccharide chain due to the different enzymes used in their
production (Table 5). The Oligomate range products offer mainly
GOS with β1→6 linkages; the Bimuno product contains mainly
β1→3 linkages, whilst Cup-Oligo, Vivinal GOS, and Purimune
offer mainly β1→4 linkages (see Table 4 for more details about
glycosidic linkage according to enzyme source).
GOS Properties
Physicochemical properties of GOS
Since commercially available food grade-GOS are mixtures
(Table 5), it is expected that their physicochemical properties
and physiological actions will, to some extent, depend on the
mixture composition, which in turn will determine its proper ap-
plication. Sweetness, solubility, osmolality, crystal formation abil-
ity, and reactivity (Maillard reactions) decrease as the molecular
size increases, contrary to viscosity (Playne and Crittenden 2009).
Table 6 presents a summary of the commonly reported GOS prop-
erties.
Physiological properties of GOS
Indigestibility. Several in vitro and in vivo experiments have
demonstrated the indigestibility and stability to hydrolysis by
digestive enzymes of GOS. In a consensus report, it was con-
cluded that more than 90% of GOS passes into the colon (van Loo
and others 1999).
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Table 6–General physicochemical properties of GOS. Adapted from Macfarlane and others (2008), Playne and Crittenden (2009), and Tzortzis and
Vulevic (2009).
Solubility Water-soluble, about 80% (w/w)
Appearance Translucent/colorless
Viscosity Similar to that of high-fructose corn syrup
Heat stability Stable to 160 ◦C for 10 min at pH 7; stable to 100 ◦C for 10 min at pH 2; stable to 37 ◦C at pH 2 for several months
Freezing point Reduces the freezing point of foods
Humectant properties High moisture retaining capacity preventing excessive drying
Sweetness Typically 0.3 to 0.6 times that of sucrose
Tri- and tetra- GOS were not hydrolyzed in vitro by human
salivary α-amylase, artificial gastric juice, α-amylase of hog pan-
creas, and rat intestinal acetone powder. Contrarily, disaccharides
were partially digested by the intestinal enzymes (Chonan and
others 2004). In another study, only a very small amount of 4′-
galactosyllactose was digested by the homogenate of the rat small
intestinal mucosa (Ohtsuka and others 1990b).
Most of the in vivo human data regarding the nondigestibility
of GOS were obtained by hydrogen breath tests. Breath hydro-
gen excretion is likely to be a dose-dependent effect. Using this
noninvasive technique, several studies reported an increased breath
hydrogen excretion when the ingested GOS amount was between
15 to 35 g/d, indicating that GOS escaped digestion and were fer-
mented by the colonic microbiota (Tanaka and others 1983; Alles
and others 1999; Chonan and others 2004). However, Bouhnik
and others (1997) showed reduced breath hydrogen after admin-
istration of a 10-g daily dose of GOS but, at the same time, bifi-
dobacterial numbers were increased, indicating that the GOS were
fermented by colonic microbiota (Bouhnik and others 1997). It
has also been shown that dietary GOS can be detected in feces of
infants fed with formula containing GOS (Moro and others 2005).
European regulation on food labeling obliges the manufactur-
ers of GOS-containing food products to clearly identify these
ingredients as dietary fiber. According to the recent legal def-
inition, fiber means “carbohydrate polymers with 3 or more
monomeric units, which are neither digested nor absorbed in the
human small intestine obtained from food raw material by phys-
ical, enzymatic, or chemical means and which have a beneficial
physiological effect demonstrated by generally accepted scientific
evidence” (European Directive 2008). Usually, the amount of di-
etary fiber that appears on food labels is determined according
to the methodology outlined in the Official Methods of Analy-
sis from the Association of Official Analytical Chemists (AOAC
1995; DeVries 2004). However, this methodology is not suitable
for measuring nondigestible oligosaccharides requiring the devel-
opment of new methods. Specifically, for GOS analysis, a method
based on the enzymatic treatment with β-galactosidase followed by
high-performance anion-exchange chromatography, using pulsed
amperometric detection (HPAEC-PAD), has been adopted (De
Slegte 2002; AOAC 2005).
Because GOS are indigestible, but fermentable (see below),
the caloric value of GOS, as well as that of other nondigestible
oligosaccharides, has been estimated to be 1 to 2 kcal/g (Rober-
froid and others 1993; Cummings and others 1997). For food
labeling purposes, in Europe, GOS should be given a caloric value
of 2 kcal/g (European Directive 2008).
Prebiotic properties. The main physiological effects of GOS
are related with their impact on the composition and activities
of the intestinal microbiota. The human intestinal tract harbors a
complex community of bacteria, eukaryotic microorganisms, ar-
chaea, viruses, and bacteriophages, collectively referred to as the
intestinal microbiota. Bacteria account for the majority of these
microorganisms: their total number in the human gut is estimated
at 1014 cells mainly present in the colon (Backhed and others 2005;
Lupp and Finlay 2005). Colonization of the gastrointestinal tract
with intestinal microbiota occurs immediately after birth and lasts
a lifetime. In adults, the composition of the colonic microbiota is
generally estimated to comprise more than 500 bacterial persis-
tent and transient species (based on worldwide observations, not
1 individual person), although it is thought that only 30 to 40 of
them predominate (McCartney and Gibson 2006). The majority
of the members of the colonic microbiota are obligate anaerobic
genera, including Bacteroides, Bifidobacterium, Clostridium, Entero-
coccus, Eubacterium, Fusobacterium, Peptococcus, Peptostreptococcus, and
Ruminococcus (McCartney and Gibson 2006).
Recent advances in defining the quality, quantity, and physi-
ologic activity of the intestinal microbiota have been possible as
a result of the advent of metagenomics (the analysis of collective
genomes of microbes), an emerging field in which the power of
genomic analysis is applied to entire microbial consortia (Gill and
others 2006). Collectively, human microbiota contains at least 100
times as many genes as the human genome corresponding to a
degree of metabolic activity that is increasingly being recognized
(Gill and others 2006; Wikoff and others 2009). This metabolic
activity includes: the ability to metabolize, otherwise indigestible,
saccharides of our diet by fermentation to various short-chain
fatty acids (SCFAs); influencing host genes that regulate energy
expenditure and storage; contributing to several biosynthetic path-
ways (including vitamins and isoprenoid precursors); production
of conjugated linoleic acid (CLA) isomers, and bioactive peptides,
with recognized health effects; promoting host homeostasis; and
decontaminating the intestine, thereby minimizing exposure to
toxic substances that could result in malignancies (Sekirov and
Finlay 2006; Ross and others 2010).
Production of SCFAs is one of the most important physio-
logical actions mediated by the microbiota. These are absorbed
resulting in energy salvage from indigested food. Moreover, SC-
FAs affect colonic epithelial cell transport, energy transduction in
colonocytes, growth, and cellular differentiation. These trophic
properties have important physiological implications, in addition
to maintaining the mucosal defense barrier against invading organ-
isms. When absorbed into the bloodstream, they affect the hepatic
control of lipid and carbohydrate metabolism and provide energy
to muscle, kidney, and brain (Cummings 1995).
The colonic microbial ecosystem is quite stable but can be
influenced by genotype, age, diet, and health status (Lupp and
Finlay 2005). Three approaches are used to beneficially modu-
late the gastrointestinal microbiota: (1) by directly supplementing
the intestinal microbiota by consuming live bacteria, ‘‘probiotics’’;
(2) by consuming dedicated dietary components selectively used
by resident microorganisms, ‘‘prebiotics’’; or (3) by combining
both strategies, “synbiotics.” A prebiotic is defined as “a selec-
tively fermented ingredient that allows specific changes, both in
the composition and/or activity in the gastrointestinal microbiota
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that confers benefits upon host wellbeing and health” (Gibson
and Roberfroid 1995; Gibson and others 2004a). The selective
properties of prebiotics are supposed to relate to the growth of
bifidobacteria and lactobacilli at the expense of other groups of
bacteria in the gut (Macfarlane and others 2006). Along with in-
ulin, fructo-oligosaccharides (FOS), and lactulose, GOS are also
food ingredients that have been consistently established as pre-
biotic ingredients from several studies conducted in vitro and in
vivo (animal and human) (Gibson and others 2004a; Rastall 2006;
Roberfroid 2007; Tzortzis and Vulevic 2009).
It was shown in Table 4 and 5 that the differences in DP and
structures of the oligosaccharides present in GOS mixtures occur
mainly due to the different enzymes used for their production.
These differences are expected to be important when it comes
to GOS assimilation by bifidobacteria in the colonic microbiota
(Tzortzis and Vulevic 2009). In a recent study, the administration
of a GOS mixture (3.6 g/d) containing mainly β1→3, as well as
β1→4 and β1→6 linkages, proved to have a better bifidogenic
effect than a GOS mixture (4.9 g/d) containing mainly β1→4, as
well as β1→6, after 1 wk of intake by healthy humans (Depeint
and others 2008). Both mixtures had mainly di- and trisaccharides.
Both these GOS mixtures had low polymerization degree with
DP ≥4 accounting for less than 12% and 19% of total saccharides,
respectively.
Most of the prophylactic health effects proposed for GOS arise
from their selective consumption by bifidobacteria and lactobacilli,
as a fermentative substrate. These reported health effects have been
recently reviewed by other researchers (Gibson and others 2004b;
Macfarlane and others 2008; Playne and Crittenden 2009; Tzortzis
and Vulevic 2009) and include protection against enteric infec-
tions; increased mineral absorption; immunomodulation for the
prevention of allergies and gut inflammatory conditions; trophic
effects of SCFAs on the colonic epithelium; fecal bulking; and re-
duced toxigenic microbial metabolism that may reduce risk factors
for colon cancer.
GOS in infant milk formulas. The significance of a
bifidobacteria-predominant microbiota in healthy breast-feed in-
fants is well accepted (Fanaro and others 2003). At that time, the
microbiota organisms are believed to be particularly important for
the correct functioning of the gut and maturation of the immune
system. Bifidobacteria and, to a lesser degree lactobacilli, may ac-
count for as much as 90% of the total microbiota in breast-fed
infants, while formula-fed infants have a more diverse microbiota
composition with greater numbers of more potentially harmful
organisms such as clostridia and enterococci (Harmsen and others
2000). Oligosaccharides in human milk can reach concentrations
as high as 8 to 12 g/L, which is 100 times greater than in cow’s
milk (Kunz and others 2000), mainly composed of sialic acid, N-
acetylglucosamine, L-fucose, D-glucose, and D-galactose (Boehm
and others 2005). One characteristic of human milk oligosac-
charides is the large amount of galactose. The backbone struc-
ture is based on lactose (galactose-glucose) plus a further galactose
residue forming the 3 different GOS, namely, 3′-galactosyl-lactose,
4′-galactosyl-lactose, and 6′-galactosyl-lactose (Boehm and others
2005). The preponderance of bifidobacteria in breast-fed babies
is thought to result from their abilities to use oligosaccharides in
breast milk, including GOS (Newburg 2000; Fanaro and others
2003).
The recognized bifidogenic effect of human milk can be repli-
cated using GOS, alone or with FOS, to fortify infant cow’s milk-
based formulas (Bakker-Zierikzee and others 2005; Fanaro and
others 2005, 2009; Knol and others 2005a, 2005b; Boehm and
Moro 2008). Additionally, the ability of GOS to resemble glyco-
conjugate structures on cell surface receptors, used by pathogens
for adherence in the gut, may also protect the colonization and
growth of pathogens during this vulnerable period (Kunz and oth-
ers 2000; Newburg 2000; Boehm andMoro 2008; Macfarlane and
others 2008).
GOS Applications
GOS are mainly used in infant milk formula, follow-on formula,
and infant foods (Playne and Crittenden 2009). Supplemented
infant formulas usually contain 6.0 to 7.2 g/L GOS together with
0.6 to 0.8 g/L FOS (Rastall 2006; Playne and Crittenden 2009).
Because of their stability, in addition to infant foods, GOS can
also be incorporated into a wide variety of other foods. Re-
cently, they have been used in beverages (fruit juices and other
acid drinks), meal replacers, fermented milks, flavored milks, and
confectionery products (Affertsholt-Allen 2007). Bread, as most
other baked goods, is a suitable candidate for GOS incorpora-
tion because during the fermentation and baking processes, GOS
molecules are not cleaved or consumed. Furthermore, due to the
high moisture retaining capacity of GOS, excessive product dry-
ing is prevented conferring this bread a better taste and texture.
Specialized foods for the elderly and hospitalized people are also
promising fields of application of GOS (Sako and others 1999).
As other nondigestible oligosaccharides, GOS have a pleasant
taste and can increase the texture and mouthfeel of foods provid-
ing bulk properties similar to sucrose. GOS are resistant to salivary
degradation and are not used by the oral microbiota and can there-
fore be used as low-cariogenic sugar substitutes. Being indigestible
they have negligent impact on blood glucose (Prapulla and others
2000).
Besides the food sector, other areas, such as the cosmetic and
pharmaceutical industries, can also exploit the physicochemical
and physiological properties of GOS. Indeed, prebiotic oligosac-
charides can selectively stimulate “beneficial” bacteria on human
skin and some formulations for that purpose have already been
developed (Bockmu¨hl and others 2007; Krutmann 2009).
The use of nondigestible oligosaccharides in the livestock feed
and pet food industries is also increasing. GOS are finding in-
creased use in the poultry (Biggs and others 2007; Jung and others
2008; Yang and others 2009), pig (Houdijk and others 1997, 1998;
Tzortzis and others 2005a; Modesto and others 2009), and aqua-
culture (Burr and others 2008; Grisdale-Helland and others 2008)
industries for improving health and growth; improving gut mi-
crobial ecology, minimizing the use of antibiotics; prevent early
mortality; and reduce fecal odor. GOS have also been applied to
suppress methane production by ruminants (Mwenya and others
2004a, 2004b; Santoso and others 2004; Sar and others 2004; Iqbal
and others 2008).
Regulatory and Safety Aspects of GOS
GOS have a generally recognized as safe (GRAS) status in the
United States, a non-Novel Food status in the EU, and are regarded
as foods for specific health use (FOSHU) in Japan, (Tzortzis and
Vulevic 2009) due to the fact that they are components of human
milk and traditional yogurt and can be produced from ingested
lactose by the resident intestinal bacteria. The only adverse effect
of GOS known so far is transient osmotic diarrhea that occurs
when an excess of GOS is consumed, similar to unabsorbed sugar
alcohols or lactose (in symptomatic lactose-intolerant individuals).
The amount of GOS that does not induce osmotic diarrhea has
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been estimated to be approximately 0.3 to 0.4 g/kg body weight,
or about 20 g per human body (Sako and others 1999).
Actually, in Europe, health claims on foods, specifically “gen-
eral function” claims are being regulated under Article 13.1 in
Regulation (EC) 1924/2006 of the European Parliament and of
the Council of 20 December 2006 on nutrition and health claims
made on foods (European Regulation 2006). The European Food
Safety Authority (EFSA) is evaluating the fundamental science
beyond the claims provided by all member states. Although not
yet authorized, in the meantime, 3 claims on GOS have already
passed EFSA’s pre-screening, namely: “maintains a healthy normal
digestive system,” “prebiotic/bifidogenic,” and “calcium absorp-
tion” (EFSA 2010a, 2010b). However, the following claims on
GOS: “helps support a healthy immune system in an ageing pop-
ulation”; “helps to manage the symptoms associated with irritable
bowel syndrome”; and “energizes your immunity boosting bacte-
ria” or “helps boost your body’s self-defense” did not pass through
the EFSA pre-screening.
Conclusions
Several microbial glycoside hydrolases have been proposed for
the synthesis of GOS from lactose. In this context, these enzymes
fundamentally differ in their ability to catalyze the transgalacto-
sylation reaction relative to hydrolysis, and in their affinity for
the GOS formed as compared to the affinity for lactose. The fi-
nal product spectrum obtained during lactose conversion and the
glycosidic linkage between the monomers depends on the en-
zyme source and the physicochemical conditions in the catalytic
environment.
Current commercially available GOS products are mixtures of
galactose-based oligosaccharides with varying degree of polymer-
ization and linkage configuration with glucose, galactose, and
lactose. GOS mixtures are well-established prebiotic ingredients.
However, depending on their oligosaccharide composition, GOS
products vary in terms of their bifidogenic and other protective
actions.
Recent and future developments in the production of GOS aim
at delivering purer and more efficient mixtures, desirably with
narrow and specific target ranges. A better understanding of what
constitutes a “healthy” intestinal microbiota composition certainly
would contribute to that goal.
GOS are stable in wide pH and temperatures ranges and are suit-
able for several applications in the food, feed, and pharmaceutical
industries. Infant and geriatric nutrition offer the most promising
opportunities for GOS applications.
GOS are safe and well-tolerated ingredients up to intake levels
of 20 g/d; they have GRAS status in the United States, FOSHU
status in Japan, and can be included in the dietary fiber content of
foods.
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